Using this model, we identified upregulation of an inflammatory signature signaling in mouse HSPCs expressing mutated CSF3R and RUNX1. This expression signature may predispose CN patients toward leukemic transformation. This evidence concerns the gene RUNX1 and cyclic hematopoiesis.